logo

IGMS

IGM Biosciences
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

IGMS Profile

Igm Biosciences, Inc.

A clinical-stage biotech company focused on creating and developing IgM antibodies

Pharmaceutical
Invalid Date
09/18/2019
NASDAQ Stock Exchange
149
12-31
Common stock
325 E. Middlefield Road, Mountain View, CA 94043
--
IGM Biosciences, Inc., was incorporated in Delaware in August 1993 under the name Palingen, Inc. IGM Biosciences, Inc., is a biotechnology company developing IgM antibody therapies for the treatment of cancer.